We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RJF icon
101
Raymond James Financial
RJF
$31.9B
$427K 0.24%
+3,488
New +$407K
CZR icon
102
Caesars Entertainment
CZR
$6.09B
$427K 0.24%
10,219
+8,110
+385% +$304K
BKD icon
103
Brookdale Senior Living
BKD
$3.46B
$426K 0.24%
+62,801
New +$448K
IBKR icon
104
Interactive Brokers
IBKR
$40.9B
$425K 0.24%
12,196
+6,968
+133% +$216K
CC icon
105
Chemours
CC
$2.63B
$424K 0.24%
+20,884
New +$427K
HUMA icon
106
Humacyte
HUMA
$172M
$424K 0.24%
77,996
+72,816
+1,406% +$480K
ALRM icon
107
Alarm.com
ALRM
$2.5B
$422K 0.24%
+7,727
New +$474K
OTTR icon
108
Otter Tail
OTTR
$3.87B
$415K 0.24%
+5,307
New +$459K
DDD icon
109
3D Systems Corp
DDD
$423M
$414K 0.24%
+145,657
New +$419K
VRTS icon
110
Virtus Investment Partners
VRTS
$1.09B
$414K 0.24%
+1,975
New +$423K
USPH icon
111
US Physical Therapy
USPH
$1.11B
$414K 0.24%
+4,887
New +$434K
OLMA icon
112
Olema Pharmaceuticals
OLMA
$1.03B
$412K 0.23%
+34,544
New +$442K
HPE icon
113
Hewlett Packard
HPE
$63.1B
$412K 0.23%
+20,145
New +$385K
LAD icon
114
Lithia Motors
LAD
$7.62B
$411K 0.23%
1,295
+683
+112% +$190K
VVX icon
115
V2X
VVX
$2.63B
$409K 0.23%
+7,316
New +$373K
BCRX icon
116
BioCryst Pharmaceuticals
BCRX
$2.38B
$409K 0.23%
+53,763
New +$409K
DAWN
117
DELISTED
Day One Biopharmaceuticals
DAWN
$408K 0.23%
+29,254
New +$417K
MWA icon
118
Mueller Water Products
MWA
$3.89B
$407K 0.23%
+18,739
New +$377K
VRNA
119
DELISTED
Verona Pharma
VRNA
$406K 0.23%
+14,125
New +$348K
INSM icon
120
Insmed
INSM
$23.3B
$406K 0.23%
5,563
+4,559
+454% +$336K
OWL icon
121
Blue Owl Capital
OWL
$6.22B
$405K 0.23%
20,939
+17,592
+526% +$314K
SRRK icon
122
Scholar Rock
SRRK
$5.93B
$405K 0.23%
+50,522
New +$444K
RPM icon
123
RPM International
RPM
$13.4B
$404K 0.23%
+3,342
New +$387K
XIFR
124
XPLR Infrastructure LP
XIFR
$1.18B
$404K 0.23%
14,638
+7,555
+107% +$196K
ITRI icon
125
Itron
ITRI
$3.72B
$404K 0.23%
+3,783
New +$383K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.